As organizers of the Equine World Stem Cell Summit we are excited to partner with North American Veterinary Regenerative Medicine Association (NAVRMA.) They are a committee of some of the most respected research scientists and veterinary practitioners in the industry, and they share our mission to accelerate regenerative medicine to improve health and deliver cures, whether for humans or animals.
The EWSCS will feature Dr. Alan Nixon, Chair of the Board of Directors at NAVRMA, as a speaker. Dr. Nixon is the Director of the Comparative Orthopaedics Laboratory at Cornell University. Dr. Nixon obtained his veterinary degree from the University of Sydney in 1978 and completed a surgical residency and research degree at Colorado State University in 1983. 
After five years in the Department of Surgical Sciences at the University of Florida, Dr. Nixon moved to New York in 1988, where he is currently a professor in the Department of Clinical Sciences at Cornell University.
Dr. Nixon’s research includes joint pathobiology and cartilage repair with growth factor gene-enhanced chondrocyte and stem cell transplantation techniques, genetic characterization of OCD in animals and man using microarray expression studies, and clinical application of growth factor recombinant proteins and gene therapy for improved joint, tendon, and bone repair.
“We are excited to participate in the Equine World Stem Cell Summit and believe NAVRMA and EWSCS is a natural partnership,” said Dr. Nixon (pictured right). “We encourage professional improvement and the exchange of knowledge and ideas among people interested in veterinary regenerative medicine. The summit is the perfect place to share information and encourage learning not only for veterinarians and researchers, but for interested owners, riders, trainers, and breeders in the equine industry.”
Throughout the three-day conference, produced by the non-profit Regenerative Medicine Foundation, attendees will hear from industry-leading veterinarians and researchers.
As the single conference uniting the global stem cell community, the WSCS provides a platform for the equine community to interact with leading researchers and institutions, as well as industry, investor, and philanthropic groups. The conference attracts approximately 1,000 attendees from 40 countries with 225 speakers and program participants.
Registration for the Equine World Stem Cell Summit is $500 for the three-day track. Sign up online and use the code “EQUINERM” today!
To learn more about the 12th Annual World Stem Cell Summit and the Equine World Stem Cell Summit and to find out how you can get involved as a sponsor or attendee, visit www.worldstemcellsummit.com/eq
